Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study
Titel:
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study
Auteur:
Barlesi, Fabrice Vansteenkiste, Johan Spigel, David Ishii, Hidenobu Garassino, Marina de Marinis, Filippo Özgüroğlu, Mustafa Szczesna, Aleksandra Polychronis, Andreas Uslu, Ruchan Krzakowski, Maciej Lee, Jong-Seok Calabrò, Luana Arén Frontera, Osvaldo Ellers-Lenz, Barbara Bajars, Marcis Ruisi, Mary Park, Keunchil